ClinicalTrials.govpublic full text
A Trial to Evaluate the Safety and Tolerability of Namilumab (MT203) in Patients With Mild to Moderate Rheumatoid Arthritis
rheumatoid arthritis, mt203, human igg1 monoclonal antibody, gm-csf monoclonal antibody, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 979062
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.